SEC Form 4 · accession 0001140361-15-004768
IDEXX LABORATORIES INC /DE · IDXX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Thomas Craig
Director
Period of report
Feb 5, 2015
Accepted (ET)
Feb 9, 2015 · 1:00 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000874716
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Feb 5, 2015 | M | 734 | $56.95 | A | 13,218 | D | |
| Common StockF1 | Feb 5, 2015 | S | 734 | $156.5722 | D | 12,484 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $56.95 | Feb 5, 2015 | M | 734 | D | — | Feb 13, 2015 | Common Stock | 734 | 0 | D |
Explanation of responses
- F1The sale price reported reflects the weighted average sale price of multiple transactions on the reported date at prices that ranged from $156.50 to $156.64, inclusive. The reporting person hereby undertakes to provide upon request to SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range.
- F2Grant of options to buy shares of common stock that vested on 02/14/2009.